Xenical Research Today is a free monthly online journal that collates and summarizes the latest research about Xenical, including details on orlistat, side-effects, obesity, weight loss, dieting.

Volume 3 (2006), Issue 10 (October)

1. Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor.
   FASEB J, 20(12): 2027-35. [Abstract] [Full-text]
2. Adherence, behavior change, and visualization: a qualitative study of the experiences of taking an obesity medication.
   J Psychosom Res, 61(4): 545-52. [Abstract] [Full-text]
3. The community management of chylous fistula using a pancreatic lipase inhibitor (orlistat).
   Laryngoscope, 116(10): 1934-5. [Abstract] [Full-text]
4. Current and novel approaches to the drug therapy of obesity.
   Eur J Clin Pharmacol, 62(10): 793-803. [Abstract] [Full-text]
5. Safety profile of orlistat: results of a prescription-event monitoring study.
   Int J Obes (Lond), 30(11): 1645-52. [Abstract] [Full-text]
6. Appetite suppression through delayed fat digestion.
   Physiol Behav, 89(4): 563-8. [Abstract] [Full-text]

© 2004-2008 Xenical Research Today. All Rights Reserved.